Zobrazeno 1 - 10
of 2 206
pro vyhledávání: '"Drug supply"'
Publikováno v:
INSEAD Working Papers Collection. 2024, Issue 18, preceding p1-8. 9p.
Autor:
Erowati, Tenny Inayah1, Herowati, Rina2, Purwidyaningrum, Ika1, Widodo, Gunawan Pamudji1, Oetari, R. A.1, Atmadani, Rizka Novia3, Rachmawati, Hidajah3 hidajah@umm.ac.id
Publikováno v:
Journal of Advanced Pharmacy Education & Research [JAPER]. Apr-Jun2024, Vol. 14 Issue 2, p42-49. 8p.
Autor:
Lunyova, Yelena A.1 e.a.luneva97@mail.ru
Publikováno v:
Research Results in Pharmacology. 2023, Vol. 9 Issue 3, p1-9. 9p.
Autor:
Fry, Erika (AUTHOR)
Publikováno v:
Fortune. 6/1/2018, Vol. 177 Issue 6, p134-144. 9p. 6 Color Photographs, 1 Chart.
Autor:
Nabity, Scott A.1,2 scott.nabity@cdph.ca.gov, Agraz-Lara, Rocio3,4, Bravo, Angelito4,5, Benjamin, Robert4,6, Fong, Vanessa1,2, Lam, C. Kin1,2, Keh, Chris1, Mase, Sundari4,6,7, Flood, Jennifer1
Publikováno v:
MMWR: Morbidity & Mortality Weekly Report. 1/5/2024, Vol. 72 Issue 52/53, p1390-1391. 2p.
Autor:
Brendan Saloner, Olivia K. Sugarman, Lauren Byrne, Samantha Harris, Molly C. Reid, Hridika Shah, Eric Hulsey, Adrienne Hurst, Lindsey Kerins, Dionna King, Susan Sherman, Emily Kaner, Daliah Heller, Sachini Bandara
Publikováno v:
Harm Reduction Journal, Vol 21, Iss 1, Pp 1-9 (2024)
Abstract Background Amidst a national surge in overdose deaths among racial and ethnic minoritized people and people who use stimulants (cocaine or methamphetamines), our objective was to understand how these groups are adapting to a rapidly changing
Externí odkaz:
https://doaj.org/article/69ea42f0d6af4bdf8bf14c5055c34bb2
Autor:
Kerstine Carter, Olga Kuznetsova, Volodymyr Anisimov, Johannes Krisam, Colin Scherer, Yevgen Ryeznik, Oleksandr Sverdlov
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-22 (2024)
Abstract Background When running a randomized controlled trial (RCT), a clinical site may face a situation when an eligible trial participant is to be randomized to the treatment that is not available at the site. In this case, there are two options:
Externí odkaz:
https://doaj.org/article/6409d535618d494eb89ff5cf9a7acc55
Autor:
PRODANOVA, Natalia Alekseevna1 prodanova-00@mail.ru, ZATSARINNAYA, Elena Ivanovna1, MOTOVILOVA, Marina Alexandrovna2, GURYANOVA, Irina Edwardovna3, PETRENKO, Elena G.4, GAVRILIEVA, Nadezhda Konstantinovna5
Publikováno v:
Propósitos y Representaciones. 2021 Special Issue, Vol. 9, p1-9. 9p.
Autor:
William H. Eger, Marina Plesons, Tyler S. Bartholomew, Angela R. Bazzi, Maia H. Hauschild, Corbin C. McElrath, Cyrus Owens, David W. Forrest, Hansel E. Tookes, Erika L. Crable
Publikováno v:
Harm Reduction Journal, Vol 21, Iss 1, Pp 1-10 (2024)
Abstract Background Xylazine is an increasingly common adulterant in the North American unregulated drug supply that is associated with adverse health outcomes (e.g., skin infections, overdose). However, there are significant knowledge gaps regarding
Externí odkaz:
https://doaj.org/article/69390191dabe442580ec9cb3b21742a9
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Drug shortage is a worldwide problem that seriously threatens public health. China released the most comprehensive list of key drug shortage monitoring varieties ever in 2022. We aim to analyze the attributes and characteristics o
Externí odkaz:
https://doaj.org/article/7ee2025d5db54a1b9b241dfa1ac307ee